| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6184185 | Gynecologic Oncology | 2015 | 9 Pages |
Abstract
Our study suggested that A2160 may be a useful biomarker to distinguish early-stage OCCC from endometrioma. This new biomarker can be potentially applied for the monitoring of endometrioma patients, making possible the early diagnosis of OCCC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Mikio Mikami, Kazuhiro Tanabe, Koji Matsuo, Yuko Miyazaki, Masaki Miyazawa, Masaru Hayashi, Satoshi Asai, Masae Ikeda, Masako Shida, Takeshi Hirasawa, Nozomi Kojima, Ryuichiro Sho, Sadayo Iijima,